We are live on ! Find out more
ZIM

Zacks Investment Management Portfolio holdings

AUM $12.5B
1-Year Est. Return 29.36%
This Fund
S&P 500
This Quarter Est. Return
+0.59%
1 Year Est. Return
+29.36%
3 Year Est. Return
+98.03%
5 Year Est. Return
+139.15%
10 Year Est. Return
+465.5%
AUM
$3.15B
AUM Growth
-$6.51M
Cap. Flow
+$3.81M
Cap. Flow %
0.12%
Top 10 Hldgs %
16.98%
Holding
802
New
188
Increased
241
Reduced
179
Closed
187

Top Sells

Rank Stock Value
1
ADM icon
Archer Daniels Midland
ADM
+$27.9M
2
HPQ icon
HP
HPQ
+$20.7M
3
LHX icon
L3Harris
LHX
+$14.6M
4
UNP icon
Union Pacific
UNP
+$8.58M
5
UAL icon
United Airlines
UAL
+$8.51M

Sector Composition

Rank Sector Weight
1 Financials 20.38%
2 Healthcare 13.88%
3 Technology 10.18%
4 Industrials 10.14%
5 Consumer Staples 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
76
PepsiCo
PEP
$188B
$15M 0.48%
160,694
+114
+0.1% +$10.9K
DOC icon
77
Healthpeak Properties
DOC
$14.6B
$14.7M 0.47%
442,487
-5,173
-1% -$188K
ETN icon
78
Eaton
ETN
$175B
$14.6M 0.46%
216,881
-3,183
-1% -$225K
TWX
79
DELISTED
Time Warner Inc
TWX
$14M 0.44%
160,338
+720
+0.5% +$61.4K
UHS icon
80
Universal Health Services
UHS
$10.4B
$13.9M 0.44%
97,512
-379
-0.4% -$47.5K
EMR icon
81
Emerson Electric
EMR
$87.6B
$13.8M 0.44%
248,318
-2,403
-1% -$141K
OPLN
82
Openlane
OPLN
$4.64B
$13.7M 0.43%
965,107
-11,603
-1% -$166K
WAB icon
83
Wabtec
WAB
$49.7B
$13.2M 0.42%
140,078
+132
+0.1% +$13K
HBI
84
DELISTED
Hanesbrands
HBI
$13.1M 0.42%
394,307
-16,397
-4% -$536K
CVS icon
85
CVS Health
CVS
$124B
$12.9M 0.41%
123,121
+1,449
+1% +$148K
LH icon
86
Labcorp
LH
$25.4B
$12.4M 0.39%
119,190
+18,035
+18% +$1.88M
LRCX icon
87
Lam Research
LRCX
$386B
$11.8M 0.37%
1,445,600
-182,000
-11% -$1.43M
STJ
88
DELISTED
St Jude Medical
STJ
$11.6M 0.37%
158,504
+3,322
+2% +$240K
M icon
89
Macy's
M
$6.71B
$11.1M 0.35%
163,922
-66
-0% -$4.46K
TGT icon
90
Target
TGT
$67.2B
$10.8M 0.34%
132,712
-4,342
-3% -$351K
MNK
91
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$10.8M 0.34%
91,480
+8,236
+10% +$1.02M
AOS icon
92
A.O. Smith
AOS
$8.59B
$10.8M 0.34%
298,804
-4,568
-2% -$157K
EMC
93
DELISTED
EMC CORPORATION
EMC
$10.5M 0.33%
396,631
+48,780
+14% +$1.3M
NKE icon
94
Nike
NKE
$62.4B
$10.4M 0.33%
192,322
-1,446
-0.7% -$74.1K
SBUX icon
95
Starbucks
SBUX
$119B
$10.4M 0.33%
193,230
-2,094
-1% -$106K
SNA icon
96
Snap-on
SNA
$21.5B
$9.85M 0.31%
61,823
+3,780
+7% +$583K
ILMN icon
97
Illumina
ILMN
$28.4B
$9.54M 0.3%
44,924
+5,607
+14% +$1.1M
PPG icon
98
PPG Industries
PPG
$26.2B
$9.53M 0.3%
83,100
-4,166
-5% -$476K
CL icon
99
Colgate-Palmolive
CL
$74B
$9.25M 0.29%
141,388
+431
+0.3% +$29.2K
NI icon
100
NiSource
NI
$20.7B
$9.13M 0.29%
509,445
+2,985
+0.6% +$53.1K

Similar funds

Zacks Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Zacks Investment Management held 802 positions worth $3.15B, down 0.21% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Zacks Investment Management's Q2 2015 filing shows 188 new, 241 increased, 179 reduced and 187 closed positions. Its largest new stake was Lowe's Companies: 84,825 shares worth $5.68M. The largest sale was Archer Daniels Midland, an estimated $27.9M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

  • Zacks Investment Management's largest Q2 2015 buy was Lowe's Companies: 84,825 shares worth $5.68M.
  • Zacks Investment Management added most to Intel in Q2 2015, an estimated $24.8M increase.
  • Zacks Investment Management's biggest Q2 2015 reduction was Archer Daniels Midland, cutting an estimated $27.9M.
  • Zacks Investment Management fully exited HP in Q2 2015, selling an estimated $20.7M.
  • Zacks Investment Management's ten largest holdings make up 17% of its $3.15B portfolio in Q2 2015.
  • Zacks Investment Management opened 188 new positions and closed 187 in Q2 2015.
  • Zacks Investment Management's portfolio value fell 0.21% quarter-over-quarter to $3.15B.

Based on Zacks Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.